Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study

[1]  Keith A. Johnson,et al.  Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts , 2018, Alzheimer's & Dementia.

[2]  Sterling C. Johnson,et al.  Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau , 2018, JAMA neurology.

[3]  C. Jack,et al.  Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting , 2018, JAMA neurology.

[4]  B. Snitz,et al.  Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting , 2018, Alzheimer's & Dementia.

[5]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[6]  Keith A. Johnson,et al.  Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global &bgr;-Amyloid Burden , 2017, JAMA neurology.

[7]  W. Jagust,et al.  Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly , 2017, Neurology.

[8]  M. D. de Leon,et al.  Sex differences in Alzheimer risk , 2017, Neurology.

[9]  Reisa A. Sperling,et al.  Harvard Aging Brain Study: Dataset and accessibility , 2017, NeuroImage.

[10]  Michael Wagner,et al.  Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. , 2017, Journal of Alzheimer's disease : JAD.

[11]  F. Pasquier,et al.  Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging , 2016, Alzheimer's & dementia.

[12]  Colin L. Masters,et al.  A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease , 2016, Journal of Molecular Neuroscience.

[13]  W. M. van der Flier,et al.  Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. , 2015, Journal of Alzheimer's disease : JAD.

[14]  Renaud La Joiea,et al.  Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and b -amyloid imaging , 2016 .

[15]  W. M. van der Flier,et al.  Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. , 2015, Journal of Alzheimer's disease : JAD.

[16]  J. Becker,et al.  Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study. , 2015, Journal of Alzheimer's disease : JAD.

[17]  Oscar L Lopez,et al.  Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[18]  D. Y. Lee,et al.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. , 2015, JAMA.

[19]  Matthew L Senjem,et al.  Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span. , 2015, JAMA neurology.

[20]  C. Hertzog,et al.  Correlates and Moderators of Change in Subjective Memory and Memory Performance: Findings from the Health and Retirement Study , 2015, Gerontology.

[21]  C. Rowe,et al.  Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. , 2015, Neuropsychology.

[22]  Keith A. Johnson,et al.  The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.

[23]  Andrew J. Saykin,et al.  A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.

[24]  Rebecca A Betensky,et al.  Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease , 2014, Neurology.

[25]  J. Karlawish,et al.  The A4 Study: Stopping AD Before Symptoms Begin? , 2014, Science Translational Medicine.

[26]  Owen Carmichael,et al.  Everyday Cognition in Older Adults: Associations with Neuropsychological Performance and Structural Brain Imaging , 2013, Journal of the International Neuropsychological Society.

[27]  Matthew L Senjem,et al.  Indicators of amyloid burden in a population-based study of cognitively normal elderly , 2012, Neurology.

[28]  Reisa A. Sperling,et al.  Subjective cognitive complaints and amyloid burden in cognitively normal older individuals , 2012, Neuropsychologia.

[29]  M. Mintun,et al.  Amyloid deposition, hypometabolism, and longitudinal cognitive decline , 2012, Annals of neurology.

[30]  G. Small,et al.  Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia , 2012, International Psychogeriatrics.

[31]  Elizabeth C Mormino,et al.  Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. , 2012, Archives of neurology.

[32]  R. Sperling,et al.  Specific Subjective Memory Complaints in Older Persons May Indicate Poor Cognitive Function , 2011, Journal of the American Geriatrics Society.

[33]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[34]  J. Morris,et al.  Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans , 2010, Alzheimer's & Dementia.

[35]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[36]  Kathleen Baynes,et al.  The measurement of everyday cognition (ECog): scale development and psychometric properties. , 2008, Neuropsychology.

[37]  Mony J. de Leon,et al.  Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints , 2008, Biological Psychiatry.

[38]  K. Blennow,et al.  Cerebrospinal Fluid Biomarkers Predict Decline in Subjective Cognitive Function over 3 Years in Healthy Elderly , 2007, Dementia and Geriatric Cognitive Disorders.

[39]  C. Jonker,et al.  Are memory complaints predictive for dementia? A review of clinical and population‐based studies , 2000, International journal of geriatric psychiatry.

[40]  Deborah Blacker,et al.  Development and Validation of a Structured Telephone Interview for Dementia Assessment (STIDA): The NIMH Genetics Initiative , 1997, Journal of geriatric psychiatry and neurology.